Associate Professor Eda Tanrikulu Simsek
7
reviews
09/03/2025
A separate thank you to the medical coordinators for their help throughout the entire treatment.
14/02/2025
We are very grateful to the oncologists and the clinic staff for their support, attentiveness, and humane attitude.
27/11/2024
I especially want to note the attentive attitude of the doctors and the international department coordinators.
06/08/2024
I would like to express special gratitude to surgeon Dr. Kemal Raşa and oncologist Dr. Eda Şimşek for the health of my beloved woman.
And a separate thank you to the interpreter Vaide, who was with us with all her heart throughout the entire treatment. Without her support, it would have been much harder for us to make it through this journey to the end.
With great respect and gratitude to these wonderful people.
18/05/2024
You can feel a high level of organization and a strong team of specialists.
18/03/2024
A separate thank you to the staff of the international department for help with translation and organization of all processes.
29/09/2023
Eda Tanrikulu Simsek is a Turkish physician, medical oncologist, and associate professor. She works at Anadolu Medical Center in Gebze (Kocaeli) — a clinic affiliated with Johns Hopkins Medicine in the USA.
Her main clinical areas are breast cancer, urological tumors (kidney, bladder, prostate, testicles), colorectal cancer, and malignant melanoma. A particular focus is personalized treatment: selection of chemotherapy, immunotherapy, and targeted therapy based on the molecular profile of the tumor.
She graduated from Ankara University Faculty of Medicine in 2005, completed her internal medicine residency at Istanbul University Cerrahpaşa Faculty of Medicine in 2007–2012 (placing 3rd in the national subspecialty examination), and completed her subspecialty in medical oncology at Marmara University in 2017. Since December 2021, she has been working as a specialist medical oncologist at Anadolu Medical Center.
She holds the ESMO Board Certified Medical Oncologist certification — a European examination confirming that her practice meets international oncological standards. She is a member of ESMO, ASCO, and the Turkish Society of Medical Oncology.
She is engaged in active scientific work — her papers have been published in international journals, and she has participated in many international clinical trials as both an assistant and a principal investigator. In 2013, she received the Thesis Award from the Turkish Society of Hematology.
Among her international fellowships is participation in a Turkish-Chinese cooperation project — a program for exchange of experience in the treatment of colorectal cancer in Shanghai (China).
For a patient with breast cancer, urological tumors, colorectal cancer, or melanoma, this is a sound choice: a doctor with European certification and academic activity, working at an internationally affiliated clinic.
Achievements and Awards
About Associate Professor Eda Tanrikulu Simsek
Medical oncology.
Clinical focuses: breast cancer, urological oncological diseases (kidney cancer, bladder cancer, prostate cancer, testicular tumors), colorectal cancer, malignant melanoma, personalized tumor treatment.
- 2005 — medical degree, Ankara University Faculty of Medicine.
- 2006 — mandatory state service in Kars.
- 2007–2012 — internal medicine residency, Istanbul University Cerrahpaşa Faculty of Medicine.
- 2017 — subspecialty in medical oncology, Marmara University Faculty of Medicine.
- ESMO Board Certified Medical Oncologist (European Society for Medical Oncology).
- 2007–2012 — residency, Istanbul University Cerrahpaşa Faculty of Medicine, Department of Internal Medicine.
- 2013–2017 — subspecialty in medical oncology (Marmara University Faculty of Medicine).
- December 2021 — present — Specialist in Medical Oncology, Anadolu Medical Center, Gebze (Kocaeli).
Has publications in PubMed / Google Scholar.
Publications on primary central nervous system lymphomas, resumption of vemurafenib after hepatotoxicity, the impact of FDG-PET/CT on clinical staging of breast cancer prior to neoadjuvant therapy, prognostic factors of small bowel adenocarcinoma (Anatolian Society of Medical Oncology study), and a modified docetaxel/cisplatin/5-fluorouracil regimen for squamous cell carcinoma of the head and neck.
Turkish Society of Hematology Thesis Award (2013).
Participation in a Turkish-Chinese cooperation project for the exchange of experience in the treatment of colorectal cancer (Shanghai, China).
Google Scholar: verified profile via Anadolu Sağlık Merkezi — Johns Hopkins Hospital.
- European Society for Medical Oncology (ESMO) — certified member
- American Society of Clinical Oncology (ASCO)
- Turkish Society of Medical Oncology (TTOD)
- Turkish Society of Hematology (recipient of the 2013 dissertation award)
Anadolu Medical Center (Anadolu Sağlık Merkezi), Gebze (Kocaeli) — one of the leading private clinics in Turkey, affiliated with Johns Hopkins Medicine.
For an oncology patient, this is a practical setup: the clinic operates a full-fledged oncology center (Kanser Merkezi) with a multidisciplinary approach, where medical oncology, surgical oncology, radiation therapy, and nuclear medicine work together. Affiliation with Johns Hopkins means integrated treatment protocols, the ability to obtain a second opinion from Johns Hopkins doctors, exchange of experience, and regular joint consultations on complex cases.
The clinic offers modern treatment methods: chemotherapy, immunotherapy, targeted therapy based on the molecular profile of the tumor, radiotherapy, brachytherapy (including interstitial), and nuclear medicine (PET-CT, radioiodine therapy).
The clinic manages international patients: remote consultation prior to arrival, translation of medical documents, treatment coordinator, interpreter, transfer, and accommodation arrangements.
